Biblio
Journal Article
Bae J, Liu L, Moore C, Hsu E, Zhang A, Ren Z, Sun Z, Wang X, Zhu JK, Shen J, et al. IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8 T cells to overcome immunotherapy resistance in cancer. Nat Cell Biol. 2022.